INTRODUCTION
Vaccination is one of the most important achievements in medicine and immunology, and is an effective means to prevent infectious diseases. Different approaches have been successfully developed to deliver vaccines against pathogenic bacteria and viruses, including inactivated whole cell vaccines, subunit vaccines and live attenuated vaccines (Spreng et al., 2006) . Generally, live vaccines can proliferate in vivo and are able to provoke strong, long-lasting adaptive immune responses. Therefore, numerous strategies have been tried that use attenuated microbes as carriers of heterologous antigens.
Attenuated Salmonella have been shown to be excellent carriers for foreign antigens derived from bacteria, viruses, parasites or tumour cells, as vaccines developed with such carriers can stimulate strong systemic and local immune responses against the corresponding antigens in animal models (Echchannaoui et al., 2008; Kulkarni et al., 2008; Qu et al., 2008; Spreng et al., 2006; Wang et al., 2008) . Plasmidbased expression systems have been widely used in presenting foreign antigens in attenuated Salmonella, but plasmids tend to be unstable and require selection (Garmory et al., 2003; Haga et al., 2006; Isoda et al., 2007; Xu et al., 2007) . Furthermore, plasmids may have negative effects on the colonization ability of the carrier strain in vivo (Coulson et al., 1994) . Although chromosomal integration of DNA encoding the foreign antigens may solve the problem, expression of the antigens from a single locus is usually below desirable levels (Spreng et al., 2006) . Therefore, DNA encoding an abundantly expressed protein would be a desirable site for chromosomal integration of DNA encoding foreign antigens. Fimbriae, for example, are long and thread-like protein structures on the surface of bacterial cells, and a Salmonella cell usually has several hundred fimbrial fibres per cell (Klemm & Schembri, 2000) .
Fimbriae are adhesive organelles, which enable bacteria to target and colonize specific host tissues, and are well known to elicit strong humoral and cell-mediated immune responses (Ochoa-Reparaz et al., 2004; Scavone et al., 2007; Tiels et al., 2008) . They are polymers composed of large numbers of identical protein subunits called fimbrins. Thin aggregative fimbriae (called Tafi or curli in Escherichia coli) and the major subunit, AgfA (CsgA or curlin in E. coli), have been found in a wide range of Salmonella enterica subsp. enterica serovars, such as Typhimurium (S. Typhimurium) and Enteriditis (S. Enteritidis) (Doran et al., 1993) . Tafi are highly flexible for displaying a 16 aa epitope (PT3) from Leishmania major gp63 protein , and the chimeric AgfA could be detected by anti-PT3 antibody, but it was not known whether this could induce an epitope-specific immune response (White et al., 1999 (White et al., , 2000 .
In this study, we established an antigen expression model to evaluate the immune effects of the Tafi presentation system. We engineered the agfA gene of S. Typhimurium LT2 by replacing a 27 bp segment with a DNA segment encoding a T-cell epitope, i.e. Sendai virus nucleoprotein 324-332 (also called SV9) Sandberg et al., 1998; Schumacher et al., 1991) . Oral immunization of C57BL/6 mice with the engineered bacterial strains induced an epitope-specific T-cell response. When the mice were challenged with the Sendai virus, the magnitude of the infection was significantly reduced in the immunized groups compared with the control groups.
METHODS
Bacterial strains, media and growth conditions. S. Typhimurium LT2 (LT2) was grown routinely in Luria-Bertani (LB) broth or on LB agar for 14-18 h at 37 uC. LT2 or E. coli containing recombinant plasmid were grown in LB broth or on LB agar supplied with kanamycin (50 mg ml
21
) for 20-24 h at 28 uC as described by White et al. (1999) . For analysing AgfA fimbrin, LT2 strains were grown on T agar for 48-60 h at 28 uC as described by Romling et al. (1998) . For Congo red (CR) binding experiments, strains were grown on T agar supplemented with 100 mg CR ml 21 (TCR).
Construction of LT2 strains containing agfA : : SV9 in the chromosome and a LT2 DagfA strain. The chimeric agfA : : SV9 genes were generated by two-step overlap extension PCR using primers A, B-SVAA, C-SVAA and D or A, B-SVRR, C-SVRR and D (Supplementary Table S1 available with the online journal) and were cloned into pHSG415 (Fig. 1a) . The chimeric genes were recombined into the chromosome of LT2, replacing the wild-type agfA gene [ Fig.  1(a) , following procedures outlined by White et al. (1999 White et al. ( , 2007 ]. Both sides of the SV9 epitope were flanked by two alanine residues (LT2-SVAA strain) or arginine residues (LT2-SVRR strain). Using the same procedure, we replaced a DNA segment in agfA gene with several termination codons to construct an AgfA-deficient DagfA strain.
To facilitate the introduction of the SV9 epitope into AgfA with flanking residues, we changed two bases in the agfA sequence, i.e. GATGCCAGACGTC), and generated an AatII restriction site, leading to an Ala to Val change in residue 43 of the mature AgfA protein. The changes were immediately upstream to the site chosen for SV9 insertion, which was site A5 (Fig. 1) as described by White et al. (2000) . The mutated agfA gene was cloned into pHSG415 to generate pHSGAAT (Fig. 1b) . Instead of two-step overlap extension PCR, one-step PCR could create a chimeric agfA gene (Fig. 1b) using primers E-SVAA or E-SVRR and D (see Supplementary Table S1 available with the online journal), with pHSGAAT as the template. The resultant recombinant plasmids, pHSGSVAa and pHSGSVRa, were used to construct two bacterial strains in which SV9 was flanked by AA (LT2-SVAAa strain) or RR (LT2-SVRRa strain). PCR using primers SV9 and D was performed to certify the insertion of SV9 DNA into agfA in the chromosome of the LT2 strains. For final confirmation of gene replacement, fragments containing agfA and the surrounding DNA region were amplified with primers agf1 and agf2, and sequenced by BGI LifeTech. Restriction enzymes and the highfidelity Taq enzyme were supplied by New England Biolabs, and ligase was purchased from Promega.
CR binding assay. The CR binding assay was performed as described by White et al. (2000) . LT2 and LT2-SV9 mutant strains were grown on TCR plates; cells were scraped off the plates and suspended in 10 mM Tris buffer (pH 7.0) at an A 650 value of 1. The cell suspension was equilibrated for 1 h and 1 ml aliquots were transferred into Eppendorf tubes containing 1 drop (50 ml) of 30 % PEG8000 in 100 mM Tris buffer (pH 7.0). Cells were removed from the suspension by centrifugation (15 000 g for 5 min) before determining the amount of CR released into the supernatant by measuring the absorbance at 480 nm using a spectrophotometer.
SDS-PAGE and Western blotting. Bacterial cells were harvested from T agar plates, suspended in Tris buffer (10 mM Tris, pH 7.5) and mixed with an equal volume of 26SDS-PAGE sample buffer containing 0.2M glycine (pH 2). The mixture was boiled for 10 min and cell debris was sedimented by centrifugation (15 000 g for 5 min). The insoluble pellet was washed with distilled water and treated with 90 % formic acid, then lyophilized (Collinson et al., 1991) . Samples were dissolved in 16SDS-PAGE loading buffer and loaded immediately on SDS-PAGE gels. SDS-PAGE was performed with a 5 % acrylamide stacking gel and 15 % acrylamide resolving gel. Proteins were electrophoretically transferred to nitrocellulose. Western blotting was performed using rabbit anti-AgfA antiserum (Collinson et al., 1991) .
Immunofluorescence. Bacterial cells were heat-fixed on glass slides prior to incubation with AgfA-specific rabbit immune serum. The secondary antibody, Alexa Fluor 488 goat anti-rabbit IgG(H+L), was purchased from Invitrogen. Cells were examined with a fluorescence microscope BX60-32FB3-E01 (Olympus) using a 1006 magnification oil-immersion lens and photographed.
Animal immunization. Female C57BL/6 mice, 6-8 weeks of age, were obtained from the Department of Experimental Animal of Peking University Health Science Center (Beijing, PR China) and maintained in a pathogen-free facility. Six mice per group were immunized with wild-type LT2, LT2-SVAA, LT2-SVAAa, LT2-SVRR and LT2-SVRRa strains. Each mouse was administered a dose of 10 7 c.f.u. bacteria orally in 100 ml saline (0.9% NaCl) by pipette. Oral immunization was repeated twice, at intervals of 14 days, for a total of three immunizations.
Enzyme-linked immunosorbent spot (ELISPOT) assay. The SV9 peptide, FAPGNYPAL, was synthesized by BGI Life Tech (Beijing, China). The mouse gamma interferon (IFN-c) ELISPOT kit was purchased from U-CyTech Biosciences. Mice were euthanized 1 week after the last immunization and their spleens were removed. Monosplenocytes were prepared and cultured for 7 days in RPMI 1640 (Invitrogen) supplemented by 10 % calf serum (Hyclone), 100 mg streptomycin ml 21 , 100 U penicillin ml 21 and 10 U murine interleukin (IL)-2 ml 21 (Cytolab); the culture medium was refreshed every 48 h after incubation. The day before ELISPOT testing, 10 mg ml 21 of SV9 peptide was added into the cell culture clusters. Cells were collected and counted before performing the ELISPOT assay, using conditions specified by the manufacturer. Four replicates of 5610 5 and 1610 5 cells per well were added to 96-well mixed PVDF plates pre-coated with anti-mouse IFN-c antibody and each well was supplemented with 10 mg synthesized peptides ml 21 and 10 U murine IL-2 ml
. No peptides were applied to media in the negative control group. After incubation at 37 uC for 24 h without agitation, plates were washed and incubated first with a biotinylated secondary antibody and then with alkaline phosphatase-conjugated streptavidin, followed by addition of freshly prepared AEC substrate buffer (supplied with the kit). The plates were photographed and analysed with an ImmunoSpot Analyser (Cellular Technology).
Virus infection. Parainfluenza 1 (Sendai) virus was purchased from Wuhan Institute of Virology, Chinese Academy of Science (Wuhan, PR China), and was propagated in 9-day-old chicken embryos. The allantoic fluid was harvested after 72 h of inoculation and titrated on LLC-MK2 cells (Institute of Biochemistry and Cell Biology, Chinese Academy of Science) to calculate the median tissue culture infective dose (TCID 50 ). Groups of mice (n520) vaccinated with one of the five LT2 strains, along with a control group immunized with saline, were inoculated intranasally with 2610 3 TCID 50 (10 6.3 copies) Sendai virus in a total volume of 0.02 ml 10 days after the last immunization. and 8 after inoculation, 6 mice from each group of 20 were anaesthetized and euthanized by bleeding out from the vena cava inferior. Lungs were harvested and homogenized on ice in four volumes of DEPC-treated saline. Samples (100 ml) of lung homogenates were treated with 1 ml TRIzol reagent (Invitrogen) to extract RNA. The final RNA was suspended in 40 ml nuclease-free water. cDNA synthesis was performed using 10 ml RNA suspension and a RevertAid first strand cDNA synthesis kit (Fermentas International). A total of 5 ml of each cDNA suspension was used in a quantitative real-time PCR, using the following primers: 59-GGCTAACC-ACCCCTCTACAG-39 (forward), 59-TCAGAGCCTCATTGCATGT-GT-39 (reverse) and 59-FAM-CCTGTTGGCATCCTTG-39 [59-FAM (6-carboxyfluorescein)-labelled probe]. The standard curve was determined using virus dilutions of chicken embryo allantoic fluid.
The presence of infectious particles was also evaluated. After centrifugation at 12 000 g, the suspension of the lung homogenate was tested by haemagglutination of chicken red blood cells (CRBCs). Viruses at 1 : 2 dilutions in 0.5 % CRBCs were incubated for 30 min at room temperature.
Statistical analyses. Experimental data were analysed with one-way analysis of variance followed by Tukey's multiple range test for significant differences. In all cases, the criterion for statistical significance was P,0.05.
S.Typhimurium agf gene
Gene replacement Two-step overlap extension PCR Constructed in pHSG415 Fig. 1 . Schematic of the method of generating S. Typhimurium strains carrying a foreign epitope in fimbrin by a two-step PCR method (a) and a modified (simplified) one-step method (b). (a) S. Typhimurium LT2 genomic DNA was used for amplifying chimeric agfA genes by two-step overlap PCR. The chimeric genes were constructed in pHSG415, an unstable and temperature-sensitive plasmid, to generate pHSGSAV and pHSGSVR. Then, the recombinant plasmids were used to transform LT2. Finally, we isolated mutant strains through gene replacement by temperature control and biotic pressure as described by White et al. (1999) . (b) A new restriction site Aat II was introduced into the plasmid pHSGAAT with the agfA gene by the same method as shown in (a). Then, with primers D and E, and taking pHSGAAT as the template, one-step PCR was performed to generate chimeric agfA gene. The subsequent steps were the same as for (a). 
RESULTS AND DISCUSSION

Generation of mutants and CR binding
Four individual strains of S. Typhimurium LT2 were engineered to express chimeric AgfA proteins containing a Sendai viral T-cell epitope, SV9 (FAPGNYPAL) using different strategies (Fig. 1a, b ). Using the method described by White et al. (1999) (Fig. 1a) , two strains, LT2-SVAA (SV9 flanked by two alanine residues) and LT2-SVRR (SV9 flanked by two arginine residues), were constructed; the other two strains, LT2-SVAAa and LT2-SVRRa, were constructed by the simplified method (Fig. 1b) . The final strains generated by the original method and the simplified method differ by the presence of an alanine residue (SVAA and SVRR) versus a valine residue (SVAAa and SVRRa) at position 43 in mature AgfA. An AgfA-deficient strain of LT2 (DagfA) was also generated.
The five LT2 mutant strains, along with the LT2 parent, were analysed for their ability to bind the hydrophobic dye CR. The binding of CR to Salmonella strains is proportional to the relative amounts of thin aggregative fimbriae (Tafi, curli) produced (White et al., 2000) . The mutated strains had a similar morphology to the LT2 parent strain on TCR plates, indicating that the AgfA : : SV9 proteins were expressed and assembled into functional Tafi. The binding of CR by the four mutated strains with chimeric AgfA was a little lower than or equal to the parent strain, but significantly higher than DagfA strain (P,0.05) (Fig.  2a) . This verified the expression of AgfA in the constructed strains and demonstrated that insertion of SV9 did not cause significant reduction in AgfA expression.
To simplify the gene replacement procedure, we made a single amino acid mutation (AgfA protein 63-AAV) upstream of the replaced AgfA fragment. Using the modified method, we constructed the chimeric agfA fragment used in gene replacement by one-step PCR using plasmid pHSGAAT as the template, which is more convenient than two-step overlap extension PCR, especially when a large quantity of construction is needed. Our results are indicative that the amino acid mutation caused by the modified method did not affect the expression of the chimeric fimbriae. Therefore, this modified method can be used for future vaccine developments.
Expression of AgfA in LT2 strains
The expression of AgfA in LT2 strains grown on TCR plates was further examined by Western blotting and immunofluorescence using AgfA-specific immune serum. Western blotting analysis showed that the AgfA protein was expressed by all the LT2 and mutant strains except the DagfA strain, and that the expressed protein products had different molecular sizes (Fig. 2b) . The immunofluorescence showed expression of thin aggregative fimbriae on the cell surface of LT2 parent strain [ Fig. 2c(i) ] and SV9 mutant strains [ Fig. 2c(ii, iv, v, vi) ], but not the DagfA strain [ Fig. 2c(ii) ]. The differences shown by immunofluorescence may be due to the change of fimbrial structure caused by the insertion of foreign peptides. With these data we confirmed the expression of the various chimeric AgfA : : SV9 proteins in mutated LT2 strains.
Epitope-specific T-cell immune response in mice immunized with LT2 vaccine strains C57BL/6 mice were immunized with the four AgfA : : SV9 LT2 strains and the LT2 parent strain, and the epitopespecific T-cell immune response was analysed using ELISPOT. In mice, the four bacterial mutants all induced epitope-specific T-cell responses and there was no difference between these four groups (Fig. 3) . In mice immunized with the parental LT2 strain, there were no SV9-specific spot-forming cells (SFCs). This is believed to be the first report of the use of the ELISPOT assay in relation to this epitope. We concluded from these results that the LT2 mutant strains expressing chimeric AgfA : : SV9 were able to induce an epitope-specific T-cell immune response.
Infection in immunized mice after viral challenge
As a test of vaccine efficacy, groups of mice immunized with the different LT2 strains were challenged with live parainfluenza 1 (Sendai) virus. The level of viral infection was monitored by real-time PCR (see Methods). The TCID 50 of chicken embryo allantoic fluid was 1610 4 per 100 ml. The viral load in the lungs of the mice was calculated according to a standard curve established with dilutions of chicken embryo allantoic fluid.
On day 1, the viral load in each group was similar, with no statistical difference between groups (Fig. 4) . On day 4, viral loads increased in most of the mouse groups, with the greatest increase observed in control mice immunized with saline (negative control) (Fig. 4) . The parental LT2 group had a similar viral level to the LT2 mutant groups and this was much lower than the saline group, which may be explained by the fact that many kinds of cytokines and chemokines can be produced, such as tumour necrosis factor alpha, IL-1, IL-6, IL-12, IL-18 and IFN-c (reviewed by Mittrucker & Kaufmann, 2000) , during the initial stages of Salmonella infection, and some cytokines, such as IL-1, IFN-c, granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor, are effective in stimulating non-specific protection against Sendai virus infection (Azuma et al., 1992; Iida et al., 1989) . However, on day 8, the viral loads in all groups with SV9 mutant strains dropped to levels lower (P,0.05) than the parental LT2 group, and the parental LT2 group was similar to the saline group, because specific cellular immune response plays an important role in recovery from infection in normal mice after day 4 (Anderson et al., 1979) and parental LT2 cannot induce a virus-specific T-cell response in mice. In contrast, the depressed viral load in mice immunized with the SV9 vaccine strains was accounted for by specific cellular immunity induced by SV9 epitope on the bacterial surface. We were unable to determine any statistical differences between the four AgfA : : SV9 strains. But the result on day 8 did not correspond with the result . ELISPOT assay of IFN-c of mice spleen cells. Mice were euthanized 1 week after the last immunization and their spleens were removed. Single cell suspensions of spleen cells were prepared and cultured in RPMI 1640 for 7 days with IL-2. The day before ELISPOT testing, 10 mg SV9 peptide ml "1 was added into the cell culture clusters. ELISPOT was performed using a mouse IFN-c ELISPOT kit. The y-axis values indicate the SV9-specific SFCs (10 5 splenocytes) "1 in each group. The error bars indicate significant differences for each group. SV9-specific SFCs were observed in the SV9 groups but not in the parental LT2 group. on day 4, in which SVAA and SVRR strains did not show any protection effect, which may be explained by the fact mentioned above that specific cellular immune response is more important in recovery after day 4 (Anderson et al., 1979) . The protection was not significant on day 4, but was on day 8 in these two groups. These results demonstrated that each mutant strain expressing chimeric AgfA : : SV9 was effective in protecting the animals against viral challenge.
In conclusion, using Salmonella thin aggregative fimbriae as vectors for foreign epitopes from Sendai virus succeeded in inducing a specific cellular immune response and antiinfection immunity. This vaccine strategy has the following advantages. First, Salmonella replicates directly in lymphoid organs and antigens are presented more efficiently; second, fimbriae are strong immunogens that can serve as an effective natural adjuvant; third, epitopes have a stable and high expression in this system, which is very advantageous, since recombinant proteins introduced by conventional methods (plasmid expression and chromosomal integration of foreign DNA at a single locus) are either unstable or poorly expressed; and fourth, oral immunization is very convenient and economic. The display system in our study provides a good choice for peptide vaccination in the future to combat tumours, as well as infectious diseases.
